Epizyme, Inc.·4

Feb 9, 5:55 PM ET

Epizyme, Inc. 4

4 · Epizyme, Inc. · Filed Feb 9, 2017

Insider Transaction Report

Form 4
Period: 2017-02-08
Graf Susan E
Chief Business Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-02-08+109,866109,866 total
    Exercise: $12.45Exp: 2027-02-07Common Stock (109,866 underlying)
Footnotes (1)
  • [F1]This option was granted on February 8, 2017 pursuant to the Company's 2013 Stock Incentive Plan with respect to 109,866 shares of Common Stock, with 25% vesting on February 8, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION